LU-177 PSMA Treatment<!-- --> | <!-- -->Wetreat

+90 537 656 24 68


LU-177 PSMA Treatment

This treatment is administered to patients with metastatic prostate tumours who do not respond adequately to standard treatment protocols and/or have clinical and biochemical progression. The treatment is not applied in renal failure, severe hepatic failure, severe heart failure. Ga-68 PSMA PET/CT imaging is performed before treatment to evaluate the extent of disease and areas of involvement. If there is involvement on imaging and if complete blood count, liver and kidney function tests are within the appropriate range for treatment, treatment is planned. For each patient, 4 treatment doses are planned with 4-6 week intervals. Your treatment is administered by slow intravenous injection of the radiopharmaceutical. Very rarely, there may be temporary side effects such as mild nausea following the injection. After treatment On the 1st day, your whole body scan is performed. Since kidney dysfunction and bone marrow suppression may develop due to treatment, complete blood count and kidney function tests should be performed at the 3rd week after treatment.

You can fill out the form on WETREAT for treatment planning.

Please fill in the form so that our assistants can prepare a travel and treatment plan for you.

You can make an appointment for face-to-face doctor counselling.


+90 537 656 24 68

Moment Office
Beştepe Mahallesi 32nd Street No:1 Floor:5 Interior Door No:93 Yenimahalle / Ankara



Download Now!

Wetreat App

Get a health check for you and your loved ones fast. Find out possible causes 24/7 – no appointment needed. You can check your symptoms online from the comfort of your own home. Whatever’s bothering you, from pain, headache or anxiety to allergy or food intolerance, wetreat’s free symptom checker can help you find answers.

We will be with you soon with our mobile application.

© Copyright 2022 Hello Global.

Designed by

Incursor Logo